2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

Ultra-Short Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants

G. Gupta, I. Yakubu, A. Khan, R. Sterling
Ultrasound Assessing Donor Kidney Quality in Deceased Donor Kidney Transplantation

S. Yun¹, K. Lee¹, S. Park², J. Park¹
Ultrasound Targeted Microbubble Cavitation During Ex Vivo Normothermic Machine Perfusion Reduces Peribiliary Vascular Plexus Thrombi and Graft Injury in a DCD Liver Transplant Model

Y. Nigmet¹, C. Hughes¹, X. Chen², A. Demetris³, D. Stolz⁴, J. Pacella², A. Humar⁵, F. Villanueva²
Understanding the Heterogeneity of Alloreactive Natural Killer (NK) Cell Function in Kidney Transplant Recipients

D. Ruan, M. Fribourg, N. Chun, P. Cravedi, A. Horowitz, P. Heeger
Understanding the Impact of Financial Obstacles and Reimbursement for Lost Wages on the Decision-Making Process for Living Organ Donation

R. J. Mandell¹, A. R. Smith¹, K. A. Gifford², B. A. Hong³, N. P. Goodrich¹, A. K. Mathur⁴, M. A. Fava¹, A. O. Ojo⁵, R. M. Merion¹
Understanding The Modification Of Eplet Mismatch Risk By Immunosuppression Regimen

A. Johnson¹, X. Zhang¹, L. Gragert², C. Larsen¹
Understanding the Response of Human Lung Microvascular Endothelial Cells During Lung Transplantation via an In Vitro Model of Ischemia Reperfusion Injury

L. Chacon Alberty¹, M. King¹, G. Loor², E. Curty¹, C. Hochman-Mendez¹
Understanding Transplant Awareness in Pre-Kidney Transplant Recipients – Role of Surgeon Visit

G. Defelice, H. Harrington, M. Ratcliff, D. Moravec, E. Wands, A. Sauviac, A. Paramesh, A. Vijay
Unique Treatment of Duodenal Perforation in Middle Aged Female Patient with Liver Transplant

H. Elshebiny¹, J. Syed-Mohammed²
Unravelling the Stage-Shift of Acute Rejection by Urine QSant

W. Yazar¹, N. Titzler¹, R. Sarwal¹, M. Sarwal², S. Ghosh¹
Upregulation of Innate Immune Pathways is Associated with Increased Rejection in HIV-Infected Kidney Transplant Recipients

A. Zarinsefat¹, Y. Kelly¹, D. Dobi¹, G. Szabo¹, Z. Laszik¹, P. Stock¹, H. Braun²
Ureteral Management for Kidney Transplantation in Patients with Ileal Conduit: Finger Technique

Y. Lin, M. Eltemamy, H. Kerr, V. Krishnamurthi, D. Goldfarb, A. Wee
Urinary Cell CTOT-04 Signature is Diagnostic of Glomerulitis in Kidney Allograft Biopsies

T. Salinas¹, C. Li¹, C. Snopkowski¹, K. Chen¹, S. Albakry¹, S. Salvatore², S. Seshan², J. R. Lee¹, M. Thangamani¹, D. Dadhania¹, M. Suthanthiran¹
Urinary Cell mRNA Profile Diagnosis of Borderline TCMR in Kidney Allografts

T. Salinas¹, C. Li¹, C. Snopkowski¹, K. Chen¹, S. Albakry¹, S. P. Salvatore², S. Seshan², J. R. Lee¹, M. Thangamani¹, D. Dadhania¹, M. Suthanthiran¹
Urinary Exosomal MicroRNA Biomarkers for Antibody-Mediated Rejection After Kidney Transplantation

S. Shin, M. Kim, S. Lim, H. Kwon, J. Jung, Y. Ko, H. Kwon, Y. Kim
Urinary Metabolomic Profiling from Spontaneous Tolerant Kidney Transplanted Recipients Shows Enrichment in Tryptophan-Derived Metabolites

L. Colas¹, A. Royer², J. Massias³, M. Chesneau¹, C. Kerleau⁴, P. Guérif⁴, M. Giral⁴, Y. Guitton², S. Brouard¹
Urine-based Assay For Detection Of Acute Rejection In Pediatric Kidney Transplant Recipients

C. Crane¹, K. Zeeb², E. Phebus², C. Benavides², W. Wong³, E. Ingulli²
Use of Ancestral Genetic SNP Phenotyping to Define Genotypic Ethnicity in Solid Organ Transplant Patients

P. Jindra, T. Tu, N. D'Silva, C. T. Stewart, J. Magana, N. Chitnis
Use of Belatacept in Non-Compliant Adolescent Patients

C. McAdams¹, C. Gluck¹, E. Hilmas²
Use of Dd-cfdna to Guide Tapering of Immunosuppression Therapy in Kidney Transplant Recipients

G. Osuchukwu¹, A. Trevino¹, L. Beretich², S. McCormick², N. Kaur², R. White², P. Gauthier²
Use of De Novo mTOR Inhibitors in Highly Sensitized Kidney Transplant Recipients

J. Bastos¹, T. Freesz², C. Bisi³, C. Marinho², A. Pires², V. Colares³, R. Neto², G. Ferreira²
Use of Everolimus and Reduced Calcineurin Inhibitors in Bk Nephropathy: Insights from Follow-Up and Surveillance Biopsies

Z. S. Zaky, M. Spinner, B. Stephany
Use of Kidneys from Hepatitis C Nat Positive Donors for Uninfected Recipients: Early Results from a Rural Appalachian Kidney Transplant Program

B. Gillis¹, F. Afridi¹, R. Lopez¹, V. Chaudhary¹, D. Kannabhiran¹, C. Fagella¹, R. Zomak¹, K. Meyer¹, M. Thornberg¹, L. Biondi²
Use of Monoclonal Antibodies for Treatment of Solid Organ Transplant Recipients with COVID-19: A Single Center Experience

S. Anjan¹, C. Vu², A. Vega², M. Maxam², J. Bini Viotti³, Y. Natori¹, J. Simkins¹, A. Khatri³, A. Mattiazzi¹, R. Vianna¹, J. Cienki², L. Lee², G. Guerra¹, L. Abbo²
Use of Monoclonal Antibody Casirivimab-Imdevimab for Treatment of COVID-19 in Kidney Transplant Recipients

A. El Chediak, K. Bloch, R. Forbes, A. Langone, B. P. Concepcion, B. A. Sarrell
Use of New 2021 CKD-EPI as an Endpoint in Transplant Trials May Significantly Influence Observations

E. Yanqui¹, H. Hames¹, T. Shi², A. R. Shields¹, E. S. Woodle¹, R. R. Alloway¹
Use of Organ-Specific Chimeric Antigen Receptor Promotes Liver Recruitment of Regulatory T Cells

E. Landmann¹, P. Ruiz¹, A. Kurt¹, E. Kodela¹, M. Martinez-Llordella², A. Sanchez-Fueyo¹
Use of Pronase to Identify HLA Crossmatch Antibody Interference

N. Hendren¹, C. Lacelle¹, S. Carter¹, J. L. Grodin¹, E. Hardin², M. Farr³, S. Garg¹
Use of Targeted T-Cell Therapy (Posoleucel) for the Treatment of Epstein-Barr Virus Associated Leiomyosarcoma in an Adult Kidney Transplant Recipient: A Case Report

R. Saranu¹, S. Nikiforow², V. Jo³, H. So², P. Stowe², S. Tripathi¹, F. Cardarelli⁴, A. Chandraker¹
Use of Three-Dimensional (3D) Modeling Software for Preoperative Anatomical Assessment in Living Donor Nephrectomy

M. McCabe¹, K. Dokus², A. Nair², K. Pineda-Solis², E. Venniro¹, J. Taylor¹, M. Orloff², R. Hernandez¹, R. Kashyap²
Use of Three-Dimensional Volumetric Analysis to Monitor Acute Rejection in a Face Transplant Recipient

D. Boczar¹, H. Brydges¹, O. C. Onuh¹, B. F. Chaya¹, J. Trilles¹, R. Rodriguez Colon¹, D. J. Ceradini¹, B. E. Gelb², E. D. Rodriguez¹
Use of Viral Specific T Cell Therapy in Solid Organ Transplant Recipients – A Single Center Experience

G. McGraw¹, N. Patel², K. Patel¹, S. Bumb³, A. Govil⁴, M. Anand¹
Use The Vascularized Sentinel Skin Flap For Prophylaxis Of Antibody-mediated Rejection After Kidney Transplantation In Highly Sensitized Patients

A. Kalachyk, A. Nosik, D. Sadouski, H. Startsava
Using a Unique Repository of Pancreas Transplant Biopsies to Validate the Tissue Common Response Module (tCRM) Score as a Tool to Assess the Severity of Pancreas Transplant Rejection

Y. Kelly¹, A. Zarinsefat¹, R. Meier², M. Sarwal¹, P. Stock¹, Z. Laszik¹, T. Sigdel¹
Using mTOR Inhibitor Nanoimmunotherapy to Induce Cardiac Allograft Tolerance in Non-Human Primates

J. M. O¹, P. M. Patel², A. J. Teunissen³, C. L. Miller⁴, T. Costa¹, M. Momodu¹, D. Muldoon¹, A. Dehnadi¹, I. M. Hanekamp¹, V. Pothula⁵, R. Sanchez-Tarjuelo⁶, G. Prevot⁶, W. J. Mulder⁶, J. Allan⁷, J. Ochando⁸, J. Madsen⁹
Using Wearable Technology to Assess Activity in Children After Heart Transplant

J. B. Edelson¹, D. Gandla², S. M. Paridon¹, J. W. Rossano¹, M. J. O'Connor¹, M. Lane-Fall², B. Keating²
Utilisation and Clinical Outcomes of Kidney Transplants from Deceased Donors with Albuminuria in the UK: A Cohort Study

G. Greenhall¹, M. Robb¹, R. Johnson¹, M. Ibrahim¹, R. Hilton², L. Tomlinson³, C. J. Callaghan², C. Watson⁴
Utility of a Holistic Molecular Paradigm for Kidney Biopsy in the Clinic

S. Anand¹, J. Sanchez-Garcia¹, K. Qui², K. Pinney², A. Raza¹, T. Srinivas², D. Morris¹
Utility of Bronchoalveolar Lavage Cytology for Detection of Malignancy or Infection in Lung Transplant Recipients

G. Cerro Chiang¹, R. Rampolla²
Utility of Cytomegalovirus T-Cell Immunity Panel to Predict CMV Infections in Lung Transplant Recipients

R. W. Lincoln¹, B. J. Pierce¹, C. Pham¹, S. W. Yau², A. Goodarzi², J. G. Youssef², H. J. Huang²
Utility of Donor Derived Cell-Free DNA in Liver Transplantation

A. Zarrinpar, D. Lewis, C. Warren, S. Duarte
Utility of Four-Point Mycophenolate Mofetil Testing in a Pediatric Kidney Transplant Population

S. Sadiq, P. Brakeman, J. Brennan, E. Black
Utility of Genetic Testing in Kidney Transplant Evaluation

N. Singh¹, A. Palermini², A. Qamar¹, M. S. Naseer¹, H. Shokouh-Amiri¹, G. Zibari¹, D. Aultman¹, L. Beretich³, D. Luksic³, J. Gibson³, S. McCormick³, H. Tabriziani³, P. Billings³
Utility of Porcine Kidneys in Transplantation Model for Training General Surgery Residents

O. Eletta, V. Putatunda, D. Walls, C. Antwi-Buosiako, B. Perry, N. Maloney Patel, R. Pelletier, A. Bongu
Utility of Protocol Pancreas Biopsies for De Novo Donor-Specific Antibodies

S. Parajuli, D. Mandelbrot, J. Odorico
Utility of Urinary CTGF as a Biomarker of Progressive Allograft Dysfunction in Pediatric Renal Transplant Recipients

L. Sheward¹, J. Wedel¹, N. Rodig¹, A. Kho¹, T. Blydt-Hansen², R. B. Mannon³, D. M. Briscoe¹
Utilization and Discard of Organs from Covid -19 Infected Donors: A Us National Registry Analysis

A. Azhar¹, I. Moinuddin¹, A. B. Gungor², M. K. Morales¹, M. Z. Molnar³, B. Tanriover², G. Gupta¹
Utilization of a Pharmacy Technician to Improve Immunization Rates for Pediatric Heart and Kidney Transplant Recipients

A. Brewer¹, E. Benefield¹, S. Boehme¹, B. Jensen¹, K. Molina², C. Peterson², C. Heyrend¹
Utilizing Microporous Annealed Particle (MAP) Gel as an Immunomodulatory Carrier for Islet Delivery

M. Ma¹, P. Chhabra¹, C. Roosa², D. R. Griffin², K. L. Brayman¹
Utilizing Microsurgeon Expertise in the Salvage of Hepatic Artery Dissection

R. Sitta¹, N. Ascher², J. Roberts², M. Piper³
Utilizing Online Training Modules and Flowcharts to Maintain Regulatory Compliance with Abo Verification and Organ Check-In Procedures

L. Adamski¹, S. Ceschini², F. K. Butt³

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z